Form D · Biotechnology
SYNLOGIC, INC.
Cambridge, MA · CIK 0001527599
Offering snapshot reported Jun 18, 2019 · SEC filing
- Reported sold
- $80M Offering amount: $80M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 11, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 18, 2019 | Initial | $79,999,992 | No comparison | 1 | SEC filing |
| May 1, 2015 | Initial | $41,789,527 | No comparison | 24 | SEC filing |
| Nov 2, 2012 | Initial | $17,249,995 | No comparison | 17 | SEC filing |
| Aug 23, 2011 | Initial | $1,500,000 | No comparison | 9 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-342188
Source: Form D, filed Jun 18, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Larry Alleva | Director |
| Peter Barrett | Director |
| Aoife Brennan | Director, Executive |
| Casi De Young | Executive |
| Christopher D Earl | Director |
| Corey Goodman | Director |
| Lynne Hohlfeld | Executive |
| Patricia Hurter | Director |
| Jon Irvin | Executive |
| Elaine Jones | Director |
| Chau Khuong | Director |
| Sinil Kim | Executive |
| Paul Lammers | Director, Executive |
| Nick Leschly | Director |
| Edward Mathers | Director |
| Ed Mathers | Director |
| Evan S Melrose | Director |
| Michael Powell | Director |
| Richard P. Shea | Director |
| Todd Shegog | Executive |
| Clay Siegall | Director |
| Ana Ward | Executive |
| Matthew Winkler | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
301 Binney Street Suite 402
Cambridge, MA, 02142
Cambridge, MA, 02142